Original assessment ยท live

AIT: Hold

Published 17 Sep 2026, 18:53 BST. This is the frozen version, not the current recommendation.

Target$292.71
Target date2027-09-11
Price known at publication$323.782026-09-11

Why this assessment was issued

Stored financial statements changed; the revised figures need checking. The model version changed. Required data is available again; reconsider the suspended assessment. The published model version has been replaced. Record the new calculation basis even if the rating is unchanged. Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance.

Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance.

Supporting evidence

Quarterly sales are growing

Revenue changed +10.4% from the same quarter last year, through 2026-06-30. The previous quarterโ€™s year-on-year change was +7.3%.

Borrowing is lower relative to earnings

Net debt / EBITDA: 0.6ร— for AIT, against 2.6ร— across 12 comparable peers.

Opposing evidence

Price has outpaced earnings

Over 1 year (2025-09-12 to 2026-09-11), price changed +23.0% and trailing EPS changed +8.3%. A wider gap changes the earnings multiple; it does not establish fair value.

Less cash remains for each dollar of profit

Cash after capital spending / profit: 1.1ร— for AIT, against 1.3ร— across 9 comparable peers.

The original scenarios

ScenarioSales growthProfit marginModel value
Weaker3.8%7.5%$218.92
Central8.8%8.3%$292.71
Stronger13.8%9.2%$380.83

Method: Earnings and historical valuation. A sufficiently complete, positive earnings record allows the stock's own P/E history to be used. These scenarios are not probability intervals.

Original assumptions and checks
eps10.96
cash127130000.0
debt483444000.0
years1.1991786447638604
growth8.771036121536357
margin8.34610845138992
profit414525000.0
cash_okTrue
debt_okTrue
growths[9.152331692970716, 8.389740550101997, 7.259830520531829, 10.447772162027547]
revenue4966686000.0
downside32.38509063579931
leverage0.5789807219831788
multiple24.145575642245483
free_cash460517000.0
buy_hurdle15
volatility25.139327563942803
history_end2026-09-11
reward_risk0.0
annual_years5
usable_weeks157
history_start2023-09-15
history_weeks157
financial_date2026-06-30
interest_cover31.60410675255953
operating_cash484082000.0
uncapped_growth8.771036121536357
current_multiple29.541970802919703
projected_margin8.34610845138992
historical_margin8.34610845138992

Recent price ยท Passed. Weekly close dated 2026-09-11.

Suitable business model ยท Passed. Value operating cash flow or comparable earnings; deduct debt and other ownership claims where appropriate.

Four quarters ยท Passed. Four quarters ending 2026-06-30.

Current financials ยท Passed. Statements through 2026-06-30; factor prices dated 2026-09-11.

Annual record ยท Passed. 5 consecutive annual profit margins, including loss years.

Comparable earnings history ยท Passed. P/E is usable in 157 of 157 weeks. At least 52 usable weeks and 70% coverage are required; excluding too many loss or missing weeks would bias the target.

Earnings and price dates ยท Passed. Earnings-release EPS $10.96, for four quarters ending 2026-06-30.

Price risk ยท Passed. Risk uses the latest 52 weekly price changes.

Comparable sales growth ยท Passed. Growth uses the median of four quarterly year-on-year comparisons.

Positive statement earnings ยท Passed. Trailing statement profit is positive.

Earnings reconciliation ยท Passed. Release EPS is $10.96; statement-derived EPS is $11.30. The difference is within the 5% review threshold; this does not prove there are no unusual items.

Statement totals ยท Passed. The latest four quarters agree with the trailing snapshot within 5%.

Cash and borrowing ยท Passed. Cash generation, debt and interest-cover figures are available.

Target publication review ยท Passed. The model estimate is within SM's automatic publication range of one quarter to four times the current price. This is a review threshold, not evidence that the market price is correct.

Policy sm-review-2-research ยท Model sm-assessment-14-operating-capital ยท Data 9cea438d1c84.

Open current research โ†—

Evidence context